↵ Fardet L, Petersen I, Nazareth I. Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing’s syndrome: cohort study. BMJ2012;345:e4928.Abstract/FREE Full Text

↵ Tempark T, Phatarakijnirund V, Chatproedprai S, Watcharasindhu S, Supornsilchai V, Wananukul S. Exogenous Cushing’s syndrome due to topical corticosteroid application: case report and review literature. Endocrine2010;38:328-34.CrossRefMedlineWeb of Science

↵ Fardet L, Flahault A, Kettaneh A, Tiev KP, Genereau T, Toledano C, et al. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient’s opinion. Br J Dermatol2007;157:142-8.CrossRefMedlineWeb of Science

↵ Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, et al. Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab2001;86:117-23.Abstract/FREE Full Text

↵ Terzolo M, Reimondo G, Chiodini I, Castello R, Giordano R, Ciccarelli E, et al. Screening of Cushing’s syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy. J Clin Endocrinol Metab2012;97:3467-75.Abstract/FREE Full Text

↵ Anderson GH Jr, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens1994;12:609-15.MedlineWeb of Science

↵ Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet2006;367:1605-17.CrossRefMedlineWeb of Science

↵ Psaras T, Milian M, Hattermann V, Freiman T, Gallwitz B, Honegger J. Demographic factors and the presence of comorbidities do not promote early detection of Cushing’s disease and acromegaly. Experimental and Clinical Endocrinology & Diabetes2011;119(1):21-5.CrossRefWeb of Science

↵ Ross EJ, Linch DC. Cushing’s syndrome—killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet1982;2:646-9.CrossRefMedlineWeb of Science

↵ Plotz CM, Knowlton AI, Ragan C. The natural history of Cushing’s syndrome. Am J Med1952;13:597-614.CrossRefMedlineWeb of Science

↵ Clayton RN, Raskauskiene D, Reulen RC, Jones PW. Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab2011;96:632-42. Abstract/FREE Full Text

↵ Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab2008;93:1526-40.Abstract/FREE Full Text

Pecori Giraldi F, Ambrogio AG, de Martin M, Fatti LM, Scacchi M, Cavagnini F. Specificity of first-line tests for the diagnosis of Cushing’s syndrome: assessment in a large series. J Clin Endocrinol Metab2007;92:4123-9.Abstract/FREE Full Text

Findling JW, Raff H. Screening and diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am2005;34:385-402, ix-x.CrossRefMedlineWeb of Science

Reimondo G, Allasino B, Bovio S, Paccotti P, Angeli A, Terzolo M. Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing’s syndrome. Eur J Endocrinol2005;153:803-9.Abstract/FREE Full Text

Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B. Evidence for the low dose dexamethasone suppression test to screen for Cushing’s syndrome—recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem1997;34(part 3):222-9.MedlineWeb of Science

↵ Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2). N Engl J Med1988;319:413-20.MedlineWeb of Science